| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |